发明名称 Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them, and use thereof for treating pain and other conditions
摘要 Vanilloid receptor ligand compounds corresponding to formula I:; a process for producing such compounds, pharmaceutical compositions containing them, and the use of such compounds to treat pain and various other vanilloid receptor mediated conditions.
申请公布号 US8791268(B2) 申请公布日期 2014.07.29
申请号 US201113077452 申请日期 2011.03.31
申请人 Gruenenthal GmbH 发明人 Frank Robert;Bahrenberg Gregor;Christoph Thomas;Schiene Klaus;De Vry Jean;Saunders Derek;Przewosny Michael;Sundermann Bernd;Lee Jeewoo
分类号 A61K31/44;C07D213/62 主分类号 A61K31/44
代理机构 Crowell & Moring LLP 代理人 Crowell & Moring LLP
主权项 1. A compound corresponding to formula I: wherein n is 1 or 2; R1 represents H; F; Cl; Br; I; methyl; ethyl; —NO2; —NH2; —OH; —NH —C(═O)—R13; —OR16; —SR17; —S(═O)2—NR22R23; or —S(═O)2 —R27; R2 represents H; F; Cl; Br; I; methyl; ethyl; —NO2; —NH2; —OH; —NH—C(═O)—R13; —OR16; —SR17; —S(═O)2—NR22R23 or —S(═O)2—R27; R3 represents H; F; Cl; Br; I; methyl; ethyl; —NO2; —NH2; —OH; —NH —C(═O)—R13; —OR16; —SR17; —S(═O)2—NR22R23 or —S(═O)2 —R27; R4 represents H; F; Cl; Br; I; methyl; ethyl; —NO2; —NH2; —OH; —NH —C(═O)—R13; —OR16; —SR17; —S(═O)2—NR22R23 or —S(═O)2 —R27; R5 represents H; F; Cl; Br; I; methyl; ethyl; —NO2; —NH2; —OH; —NH —C(═O)—R13; —OR16; —SR17; —S(═O)2—NR22R23 or —S(═O)2 —R27; R6 represents hydrogen or an alkyl group selected from the group consisting of isopropyl, n-butyl, sec-butyl, isobutyl, methyl, ethyl, and n-propyl; R7 represents hydrogen or —OH; R8 represents —SF5; —O—CF3; tert-butyl or —C(CH3)2(CH2OH); T stands for C—R35; U stands for C—R36; V stands for C—R37, and W stands for C—R38; R13, R16, R17, R22, R23, and R27 each independently represent a group selected from the group consisting of methyl, ethyl, and n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, n-pentyl, and ethenyl; R35, R36, and R37 each represent H; R38 represents NHR39, wherein R39 represents methyl, ethyl, and n-propyl, n-butyl, sec-butyl, isobutyl, tert-butyl, n-pentyl, 3-pentyl, n-hexyl, or (3,3)- dimethylbutyl; —NR40R41, wherein R40 and R41 together with the nitrogen atom to which they are bound form a group selected from the group consisting of pyrrolidinyl, piperdinyl, and moropholinyl, wherein the heterocycloaliphatic moiety may be unsubstituted or substtitued by 1, 2, 3, 4, or 5 groups R57; —OR42, wherein R42 represents methyl, ethyl, n-propyl, n-butyl, sec-butyl, isobutyl, tert-butyl, n-pentyl, 3-pentyl, n-hexyl, (3,3)-dimethylbutyl, cycopentyl, or cyclohexyl; or —SR43, wherein R43 represents cyclohexyl; R57 represents an alkyl group selected from the group consisting of methyl, ethyl, n-propyl, isopropyl, tert-butyl, n-butyl, sec-butyl, and isobutyl; or a salt thereof.
地址 Aachen DE